SCHEMBL26260063

SCHEMBL26260063

COc1ccc2c(-c3ncccn3)c(OC)cc(-c3ncccn3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK4 Q9HAZ1 3/20 0.44
▸ DYRK1A Q13627 2/20 0.44
▸ RAB9A P51151 2/20 0.41
▸ SYK P43405 3/20 0.39
▸ IDH1 O75874 1/20 0.39
▸ PDE2A O00408 1/20 0.39
▸ CYP19A1 P11511 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ CYP3A4 P08684 4/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP1A1 P04798 1/20 0.37
▸ CYP2E1 P05181 1/20 0.37
▸ CYP2C8 P10632 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260030 0.80 RAB9A (0.44) RAB9ASYKKDM4ESMN1; SMN2MEN1
SCHEMBL26260094 0.77 HIF1A (0.46) CLK4DYRK1ARAB9ASYKCYP19A1
SCHEMBL29015008 0.76 CYP1A1 (0.58) CLK4DYRK1ARAB9ASYKIDH1
SCHEMBL26259504 0.73 MAPK13 (0.46) RAB9AKDM4EMEN1KMT2ACYP3A4
SCHEMBL26259484 0.73 KDM4E (0.51) RAB9AKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26260024 0.72 HCRTR1 (0.39) CLK4DYRK1AKDM4ESMN1; SMN2CYP3A4
SCHEMBL26259500 0.72 PDE4A (0.43) RAB9ASYKMEN1KMT2ACYP1A2
SCHEMBL26260021 0.72 SMPD3 (0.43) CLK4DYRK1ARAB9APDE2ACYP19A1
SCHEMBL26260061 0.72 KDM4E (0.57) CLK4RAB9ACYP19A1KDM4ECYP3A4
SCHEMBL26260037 0.70 CYP11B1 (0.53) CLK4KDM4ESMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 CLK4 2928/4885DYRK1A 3243/4885RAB9A 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback